Abstract
The solid-phase synthesis of cyclic RGD peptides containing either one or two furanoid sugar amino acids (SAAs) is reported. Using a cyclization-cleavage approach five peptides were successfully assembled and consecutively tested on their ability to bind to the integrin receptors alpha(v)beta(3) and alpha(IIb)beta(3). The cyclic tetrapeptide c[RGD-SAA] (1) showed the most promising activity in an inhibition assay with an IC(50) of 1.49 microM for the alpha(v)beta(3) receptor and 384 nM for the alpha(IIb)beta(3) receptor.
MeSH terms
-
Binding, Competitive / drug effects
-
Blood Coagulation / drug effects
-
Blood Platelets / chemistry
-
Chromatography, High Pressure Liquid
-
Cyclization
-
Humans
-
Indicators and Reagents
-
Integrin alphaVbeta3 / antagonists & inhibitors
-
Integrin alphaVbeta3 / blood
-
Integrins / antagonists & inhibitors*
-
Oligopeptides / chemical synthesis*
-
Platelet Aggregation / drug effects
-
Platelet Membrane Glycoprotein IIb / blood
-
Platelet Membrane Glycoprotein IIb / drug effects
-
Sugar Acids / chemistry*
Substances
-
Indicators and Reagents
-
Integrin alphaVbeta3
-
Integrins
-
Oligopeptides
-
Platelet Membrane Glycoprotein IIb
-
Sugar Acids
-
arginyl-glycyl-aspartic acid